Effects of pulse methylprednisolone on inflammatory mediators in peripheral blood, synovial fluid, and synovial membrane in rheumatoid arthritis

Arthritis and Rheumatism

Volumn 40, Issue 8, 1997, Pages 1400-1408

  Youssef, Peter P ^a   Haynes, David R ^b   Triantafillou, Sophie ^c   Parker, Angela ^c   Gamble, Jenny R ^d   Roberts Thomson, Peter J ^a   Ahern, Michael J ^a   Smith, Malcolm D ^a,e  

^a FLINDERS MEDICAL CENTRE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c Repatriation Hospital   (Australia)

^d INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^e REPATRIATION GENERAL HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOCYTE RECEPTOR;

ARTICLE; B LYMPHOCYTE; HUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; INTERLEUKIN-8; MALE; METHYLPREDNISOLONE; MIDDLE AGED; SYNOVIAL FLUID; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030886898     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780400807     Document Type: Article

References (40)

1. Harris ED: Rheumatoid arthritis: pathophysiology and implications for therapy. N Engl J Med 322:1277-1289, 1990
2. Costello PB, Baer AN, Green FA: Lipoxygenase products in inflammatory synovial fluids and other exudates. Ann Rheum Dis 51:1215-1218, 1992
3. Koch AE, Kunkel SL, Burrows JC, Evanoff HL, Haines GK, Pope RM, Stricter RM: Synovial tissue macrophage as a source of the chemotactic cytokine IL-8. J Immunol 147:2187-2195, 1991
4. Koch AE, Kunkel SL, Chensue SM, Haines GK, Stricter RM: Expression of interleukin-1 and interleukin-1 receptor antagonist by human rheumatoid synovial tissue macrophages. Clin Immunol Immunopathol 65:23-29, 1992
5. Chu CQ, Field M, Feldmann M, Maini RN: Localization of tumor necrosis factor α in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum 34:1125-1132, 1991
6. Youssef PP, Roberts-Thomson PJ, Ahern MJ, Smith MD: Pulse methylprednisolone in rheumatoid arthritis: effects on peripheral blood and synovial fluid neutrophil surface phenotype. J Rheumatol 22:2065-2071, 1995
7. Smith MD, Bertouch JV, Smith AM, Weatherall M, Ahern MJ, Brooks PM, Roberts-Thomson PJ: The clinical and immunological effects of pulse methylprednisolone therapy in rheumatoid arthritis. I. Clinical effects. J Rheumatol 15:229-232, 1988
8. Smith MD, Ahern MJ, Roberts-Thomson PJ: Pulse methylprednisolone therapy in rheumatoid arthritis: unproved therapy, unjustified therapy, or effective adjunctive treatment? Ann Rheum Dis 49:265-267, 1990
9. Smith MD, Ahern MJ, Brooks PM, Roberts-Thomson PJ: The clinical and immunological effects of pulse methylprednisolone therapy in rheumatoid arthritis. III. Effects on immune and inflammatory indices in synovial fluid. J Rheumatol 15:238-241, 1988
10. Youssef PP, Cormack J, Evill CA, Peter DT, Roberts-Thomson PJ, Ahern MJ, Smith MD: Neutrophil trafficking into inflamed joints in patients with rheumatoid arthritis, and the effects of methylprednisolone. Arthritis Rheum 39:216-225, 1996
11. Beutler B, Krochin N, Milsark IW, Luedke C, Cerami A: Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 232:977-980, 1986
12. Mukaida N, Morita M, Ishikawa Y, Rice N, Okamoto S, Kasahara T, Matsushima K: Novel mechanism of glucocorticoid-mediated gene repression: nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression. J Biol Chem 269:13289-13295, 1994
13. Lee SW, Tsou AP, Chan H, Thomas J, Petrie K, Eugui E, Alison AC: Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA. Proc Natl Acad Sci U S A 85:1204-1208, 1988
14. Cronstein BN, Kimmel SC, Levin RI, Martiniuk F, Weissmann G: A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci U S A 89:9991-9995, 1992
15. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medgser TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324, 1988
16. Youssef PP, Mantzioris BX, Roberts-Thomson PJ, Ahern MJ, Smith MD: Effects of ex vivo manipulation on the expression of cell adhesion molecules on neutrophils. J Immunol Methods 186:217-224, 1995
17. Remick DG, DeForge LE, Sullivan JF, Showell HJ: Profile of cytokines in synovial fluid specimens from patients with arthritis: interleukin 8 (IL-8) and IL-6 correlate with inflammatory arthritides. Immunol Invest 21:321-327, 1992
18. Kelly RW, Deam S, Cameron MJ, Seamark RF: Measurement by radioimmunoassay of prostaglandins as their methyl oximes. Prostaglandins Leukot Med 24:1-14, 1986
19. Nakai S, Mizuno K, Kaneta M, Hirai Y: A simple, sensitive bioassay for the detection of interleukin-1 using human melanoma A375 cell line. Biochem Biophys Res Commun 154:1189-1196, 1988
20. Matthews N, Neale ML: Cytotoxic assays for tumour necrosis factor and lymphotoxin. In, Lymphokines and Interferons: A Practical Approach. Edited by MJ Clements, AG Morris, AJH Ghearing. Oxford, IRL Press, 1987
21. Smith MD, Chandran G, Youssef PP, Darby T, Ahern MJ: Day case knee arthroscopy under regional anaesthesia performed by rheumatologists. Aust N Z J Med 26:108-109, 1996
22. Smith MD, O'Donell J, Highton J, Palmer DG, Rosenbilds M, Roberts-Thomson PJ: Immunohistochemical analysis of synovial membranes from inflammatory and noninflammatory arthritides: scarcity of CD5 positive B cells and IL2 receptor bearing T cells. Pathology 24:19-26, 1992
23. Skinner JM, Zhao Y, Coventry B, Bradley J: Videoimage analysis in pathology. Dis Markers 11:53-70, 1993
24. Youssef PP, Triantafillou S, Parker A, Coleman M, Roberts-Thomson PJ, Ahern MJ, Smith MD: Effects of pulse methylprednisolone on cell adhesion molecules in the synovial membrane in rheumatoid arthritis: reduced E-selectin and intercellular adhesion molecule 1 expression. Arthritis Rheum 39:1970-1979, 1996
25. Butcher EC: Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 67:1033-1036, 1991
26. Tak PP, Taylor PC, Breedveld FC, Smeets TJM, Daha MR, Kluin PM, Meinders AE, Maini RN: Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor α monoclonal antibody treatment in patients with rheumatoid arthritis. Arthritis Rheum 39:1077-1081, 1996
27. Tetta C, Camussi G, Modena V, DiVittorio C, Baglioni C: Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis. Ann Rheum Dis 59:665-667, 1990
28. Elliott MJ, Maini RN, Feldmann M, Long Fox A, Charles P, Bijl H, Woody JN: Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis. Lancet 344:1125-1127, 1994
29. Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, Leeb B, Breedveld FC, Macfarlane JD, Bijl H, Woody JN: Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet 344:1105-1110, 1994
30. Deleuran B, Lemche P, Kristensen M, Chu CQ, Field M, Jensen J, Matsushima K, Stengaard Pedersen K: Localisation of interleukin 8 in the synovial membrane, cartilage-pannus junction and chondrocytes in rheumatoid arthritis. Scand J Rheumatol 23:2-7, 1994
31. Seitz M, Dewald B, Gerber N, Baggiolini M: Enhanced production of neutrophil-activating peptide-1/IL-8 in rheumatoid arthritis. J Clin Invest 87:463-469, 1991
32. Peichl P, Ceska M, Broell H, Effenberger F, Lindley IJD: Presence of NAP-1/IL-8 in synovial fluids indicates a possible pathogenic role in rheumatoid arthritis. Scand J Immunol 34:333-339, 1991
33. Peichl P, Ceska M, Broell H, Effenberger F, Lindley IJD: Human neutrophil activating peptide/interleukin 8 acts as an autoantigen in rheumatoid arthritis. Ann Rheum Dis 51:19-22, 1992
34. Rathanaswami P, Hachicha M, Wong WL, Schall TJ, McColl SR: Synergistic effect of interleukin-1β and tumor necrosis factor α on interleukin-8 gene expression in synovial fibroblasts: evidence that interleukin-8 is the major neutrophil-activating chemokine released in response to monokine activation. Arthritis Rheum 36:1295-1304, 1993
35. Deleuran BW, Chu CQ, Field M, Brennan FM, Katsikis P, Feldmann M, Maini RN: Localization of interleukin-1 alpha, type 1 interleukin-1 receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis. Br J Rheumatol 31:801-809, 1992
36. Firestein GS, Boyle DL, Yu C, Paine MM, Whisenand TD, Zvaifler NJ, Arend WP: Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis. Arthritis Rheum 37:644-652, 1994
37. Kowanko IC, Bates EJ, Ferrante A: Platelet-activating factor inhibits proteoglycan synthesis and enhances neutrophil-mediated proteoglycan degradation in cartilage explants. Arthritis Rheum 35:918-925, 1992
38. Corkill MM, Kirkham BW, Haskard DO, Barbatis C, Gibson T, Panayi GS: Gold treatment of rheumatoid arthritis decreases synovial expression of the endothelial leukocyte adhesion receptor ELAM-1. J Rheumatol 18:1453-1460, 1991
39. Kirkham BW, Navarro FJ, Corkill MM, Panayi GS: In vivo analysis of disease modifying drug therapy activity in rheumatoid arthritis by sequential immunohistological analysis of synovial membrane interleukin 1 beta. J Rheumatol 21:1615-1619, 1994
40. Yanni G, Nabil M, Farahat MR, Poston RN, Panayi GS: Intramuscular gold decreases cytokine expression and macrophage numbers in the rheumatoid synovial membrane. Ann Rheum Dis 53:315-322, 1994